# Points of Discussion: Clinical Trials - Speed and Access

Page: https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-clinical-trials-speed-and-access
Text version: https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-clinical-trials-speed-and-access.md
Podcast: [PeDRA Pearls](https://stenobird.com/podcast/pedra-pearls-1565679)
Published: 2026-03-02T13:15:00+00:00
Episode link: https://pedraresearch.org/resources/points-of-discussion-academic-versus-private-clinical-trials/
Audio file: https://episodes.captivate.fm/episode/3f367aab-bf31-4d10-b56e-7482fd0e8269.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-clinical-trials-speed-and-access
Duration seconds: 1525

## Resource

Episode 2 explores how private‑practice and industry‑run clinical trials bring efficiency, flexibility, and broader patient access to the research landscape. Our guests discuss the financial and scientific motivations behind industry partnerships, the strengths and trade‑offs of private sites, and how these settings support large, fast‑moving studies. Rare‑disease trials, PK designs, and investigator‑initiated research are highlighted as key collaborative touchpoints. This independent medical education program is supported by Incyte. Please click here for a complete list of disclosures.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/pedra-pearls-1565679/episodes/points-of-discussion-clinical-trials-speed-and-access/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/pedra-pearls-1565679/points-of-discussion-clinical-trials-speed-and-access.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.